News Clinical Trials

FDA Explores AI to Accelerate Early-Phase Clinical Trials in Pilot Program

The FDA is turning to AI in clinical research to streamline early-phase trial reporting, with the goal of accelerating drug development and approvals.

May 06, 2026 By ASCO AI Staff 2 min read
Share
Top Institutions in Specialty Name

Methodology summary text

  • #1

    Emergency Pitt

    Pittsburgh, PA

    Key Differentiators

    • ER
    • Acting
    • Medicine

  • #1

    Emergency Pitt

    Pittsburgh, PA

    Key Differentiators

    • ER
    • Acting
    • Medicine

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content